F-1/A: Inspira Technologies Files Amendment for Resale of Ordinary Shares and Warrants

Inspira Technologies is filing an amendment to its registration statement for the resale of ordinary shares and warrants by selling shareholders.

Summary

• Inspira Technologies Oxy B.H.N. Ltd. has filed an amendment to its Form F-1 registration statement with the SEC.
• This amendment pertains to the offer and resale of up to 953,478 ordinary shares and 3,463,438 ordinary shares issuable upon exercise of outstanding warrants by the selling shareholders.
• The warrants have exercise prices between $1.28 and $2.25 per share.
• The company will not receive any proceeds from the sale of the resale shares, but may receive approximately $4.7 million if all warrants are exercised for cash.
• These proceeds would be used for working capital and general corporate purposes.
• The company's Ordinary Shares and IPO Warrants are listed on the Nasdaq Capital Market under the symbols IINN and IINNW, respectively.
• On May 17, 2024, the last reported sale price of the Ordinary Shares was $2.30 and the IPO Warrants was $0.55.
• Inspira Technologies is an emerging growth company and a foreign private issuer, which allows for reduced public company reporting requirements.

Sentiment

Score: 6

Explanation: The document is neutral. It primarily describes the resale of shares and warrants, with a potential for the company to receive funds if warrants are exercised. However, there are also risks associated with the offering.

Positives

• Potential influx of $4.7 million in gross proceeds if all warrants are exercised for cash, which will be used for working capital and general corporate purposes.

Negatives

• The company will not receive any proceeds from the sale of resale shares by the selling shareholders.
• There is no guarantee that the warrants will be exercised, and they may expire, resulting in no cash proceeds for the company.
• Future sales of ordinary shares could reduce the market price of the company's securities.
• The price of the Ordinary Shares may be volatile.

Risks

• Future sales of ordinary shares could reduce the market price of the company's securities.
• The price of the Ordinary Shares may be volatile.
• The company may need additional financing in the future, and may be unable to obtain additional financing or if it obtains financing it may not be on terms favorable to the company.
• The company has never paid cash dividends on its share capital, and does not anticipate paying any cash dividends in the foreseeable future.

Future Outlook

The company expects to continue developing and commercializing its life support technology, targeting intensive care units, general medical units, operating theaters, and small urban and rural hospitals.

Industry Context

The company aims to supersede traditional mechanical ventilators with its proprietary life support technology, addressing the risks and costs associated with Mechanical Ventilation.

Stakeholder Impact

• Shareholders may experience dilution if additional ordinary shares are issued.
• The company's ability to fund its operations and commercialize its products depends on its ability to raise additional capital.

Next Steps

• The selling shareholders may offer and sell the resale shares from time to time.
• The company will continue to pursue regulatory approvals and establish collaborations with strategic partners and health centers.

Key Dates

Keywords

ordinary shares, warrants, resale, Inspira Technologies, selling shareholders, registration statement, IINN, IINNW, emerging growth company, foreign private issuer